Evidence map›Paper›PMID 34834393›Full record

ReviewPharmaceutics2021

Promising Strategies of Colloidal Drug Delivery-Based Approaches in Psoriasis Management.

Sukhbir Singh, Neelam Sharma, Tapan Behl, Bidhan Chandra Sarkar, Hasi Rani Saha, Kanika Garg, Supriya Kamari Singh, Sandeep Arora, Md Shah Amran, Ahmed A H Abdellatif and 3 more

Open access · goldAbstract readReview
In one paragraph

Review in Pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Current pharmaceutical design · 2026
    Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 5 countries.

Sukhbir SinghDepartment of Pharmacology, Chitkara College of Pharmacy, Chitkara University, Rajpura 140401, Punjab, India.
Neelam SharmaDepartment of Pharmacology, Chitkara College of Pharmacy, Chitkara University, Rajpura 140401, Punjab, India.
Tapan BehlDepartment of Pharmacology, Chitkara College of Pharmacy, Chitkara University, Rajpura 140401, Punjab, India.ORCID 0000-0003-0993-7708
Bidhan Chandra SarkarDepartment of Biochemistry, Primeasia University, 12- Kemal Ataturk Avenue, HBR Tower Banani C/A, Dhaka 1213, Bangladesh.
Hasi Rani SahaDepartment of Biochemistry, Primeasia University, 12- Kemal Ataturk Avenue, HBR Tower Banani C/A, Dhaka 1213, Bangladesh.
Kanika GargDepartment of Pharmacology, Chitkara College of Pharmacy, Chitkara University, Rajpura 140401, Punjab, India.
Supriya Kamari SinghDepartment of Pharmacology, Chitkara College of Pharmacy, Chitkara University, Rajpura 140401, Punjab, India.
Sandeep AroraDepartment of Pharmacology, Chitkara College of Pharmacy, Chitkara University, Rajpura 140401, Punjab, India.
Md Shah AmranDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Dhaka, Shahbag, Dhaka 1000, Bangladesh.
Ahmed A H AbdellatifDepartment of Pharmaceutics, College of Pharmacy, Qassim University, Buraydah 51452, Saudi Arabia.
Anwar L BilgramiDeanship of Scientific Research, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0001-7270-9068
Ghulam Md AshrafPre-Clinical Research Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0002-9820-2078
Md Sohanur RahmanDepartment of Biochemistry and Molecular Biology, Trust University, Barishal, Ruiya, Nobogram Road, Barishal 8200, Bangladesh.ORCID 0000-0002-1133-268X
Chitkara University · INPrimeasia University · BDKing Abdulaziz University · SAQassim University · SARutgers, The State University of New Jersey · USUniversity of Barishal · BDUniversity of Dhaka · BD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Psoriasis is a chronic inflammatory autoimmune disorder that moderately affects social and interpersonal relationships. Conventional treatments for psoriasis have certain problems, such as poor drug penetration through the skin, hyper-pigmentation, and a burning sensation on normal and diseased skin. Colloidal drug delivery systems overcome the pitfalls of conventional approaches for psoriasis therapeutics and have improved patient safety parameters, compliance, and superior effectiveness. They also entail reduced toxicity. This comprehensive review's topics include the pathogenesis of psoriasis, causes and types of psoriasis, conventional treatment alternatives for psoriasis, the need for colloidal drug delivery systems, and recent studies in colloidal drug delivery systems for the treatment of psoriasis. This review briefly describes colloidal drug delivery approaches, such as emulsion systems-i.e., multiple emulsion, microemulsion, and nano-emulsion; vesicular systems-i.e., liposomes, ethosomes, noisomes, and transferosomes; and particulate systems-i.e., solid lipid nanoparticles, solid lipid microparticles, nano-structured lipid carriers, dendrimers, nanocrystals, polymeric nanoparticles, and gold nanoparticles. The review was compiled through an extensive search of the literature through the PubMed, Google Scholar, and ScienceDirect databases. A survey of literature revealed seven formulations based upon emulsion systems, six vesicular drug delivery systems, and fourteen particulate systems reported for antipsoriatic drugs. Based on the literature studies of colloidal approaches for psoriasis management carried out in recent years, it has been concluded that colloidal pharmaceutical formulations could be investigated broadly and have a broad scope for effective management of many skin disorders in the coming decades.

Indexed as

colloidal drug delivery systemdendrimersliposomemicroemulsionnano-structured lipid carrierpsoriasissolid lipid nanoparticles

Identifiers

PMID34834393
PMCPMC8623849
OpenAlexW3217368648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.